Lilinorm

Hydrocortisone, the active ingredient in Lilinorm, is a glucocorticoid presented as an oral tablet for oral use. It treats adrenal insufficiency and inflammatory conditions in patients who require systemic corticosteroid therapy.

GNH USA supplies Lilinorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydrocortisone is a glucocorticoid that acts on the hypothalamic‑pituitary‑adrenal axis and inflammatory pathways.

- Adrenal insufficiency: provides hormone replacement to restore cortisol levels. - Congenital adrenal hyperplasia: supplies glucocorticoid needed for metabolic control. - Inflammatory conditions: reduces systemic inflammation and associated symptoms in disorders such as rheumatoid arthritis or severe dermatitis.

Hydrocortisone may cause a range of adverse reactions, from mild to severe, depending on dose and duration of therapy.

Common Side Effects: - Hyperglycemia: elevated blood sugar levels. - Fluid retention: swelling of extremities. - Hypertension: increased blood pressure. - Mood changes: irritability or euphoria. - Gastrointestinal upset: nausea or abdominal discomfort. - Weight gain: increased appetite and fat deposition.

Serious or Rare Side Effects: - Adrenal suppression: reduced endogenous cortisol production. - Severe infection: heightened susceptibility to bacterial, viral, or fungal infections. - Cushingoid appearance: moon face, central obesity. - Osteoporosis: decreased bone mineral density. - Psychosis: hallucinations or severe mood disturbances. - Anaphylaxis: rare but life‑threatening allergic reaction.

Before initiating therapy with Hydrocortisone, clinicians should consider several safety measures.

- Monitor blood glucose: adjust antidiabetic therapy as needed. - Assess blood pressure: watch for hypertension, especially in high‑risk patients. - Evaluate for infection: treat existing infections before starting. - Adjust dose in hepatic impairment: reduce dose if liver function is compromised. - Avoid abrupt discontinuation: taper gradually to prevent adrenal crisis. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Hydrocortisone can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole): increase systemic exposure. - Anticoagulants (warfarin): may enhance anticoagulant effect. - NSAIDs: raise risk of gastrointestinal bleeding. - Live vaccines: reduced immunogenicity. - Diuretics: potentiate hypokalemia.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): decrease hydrocortisone levels. - Antidiabetic agents (insulin, oral hypoglycemics): may require dose adjustment. - Antihypertensives: possible reduction in blood‑pressure control. - HIV protease inhibitors: may increase glucocorticoid exposure. - Thyroid hormones: monitor for altered metabolism.